140 related articles for article (PubMed ID: 34339059)
1. How to improve clotting factors depletion in double-filtration plasmapheresis.
Naciri Bennani H; Marlu R; Terrec F; Motte L; Seyve L; Chevallier E; Malvezzi P; Jouve T; Rostaing L; Noble J
J Clin Apher; 2021 Oct; 36(5):766-774. PubMed ID: 34339059
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis.
Marlu R; Naciri Bennani H; Seyve L; Noble J; Chevallier E; Motte L; Imerzoukene F; Bugnazet M; Christophe M; Malvezzi P; Jouve T; Rostaing L
J Clin Apher; 2021 Jun; 36(3):408-419. PubMed ID: 33506958
[TBL] [Abstract][Full Text] [Related]
3. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.
Marlu R; Malvezzi P; Seyve L; Jouve T; Maurizi J; Defendi F; Carron PL; Christophe M; Le Gouellec A; Polack B; Rostaing L
Thromb Res; 2018 Jun; 166():113-121. PubMed ID: 29747114
[TBL] [Abstract][Full Text] [Related]
4. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.
Naciri Bennani H; Noble J; Chevallier E; Terrec F; Motte L; Giroux-Lathuile C; Bugnazet M; Imerzoukene F; Janbon B; Malvezzi P; Rostaing L; Jouve T
J Clin Apher; 2021 Feb; 36(1):149-160. PubMed ID: 33230824
[TBL] [Abstract][Full Text] [Related]
5. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
6. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
Vatazin AV; Zulkarnaev AB
Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
[TBL] [Abstract][Full Text] [Related]
7. Regional Citrate Anticoagulation during Double-Filtration Plasmapheresis in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study.
Ho QY; Teh SP; Thangaraju S; Teo SH; Tan HK; Abdul Rahman MB; Ng LC; Lim AEL; Choong LHL; Kee T; Kaushik M;
Blood Purif; 2022; 51(4):376-382. PubMed ID: 34198288
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
9. Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive Models.
Jouve T; Marlu R; Malvezzi P; Seyve L; Maurizi J; Carron PL; Polack B; Rostaing L
Blood Purif; 2018; 46(3):239-245. PubMed ID: 29972828
[TBL] [Abstract][Full Text] [Related]
10. Optimization of heparinization in clinical double filtration plasmapheresis.
Hosokawa S; Oyamaguchi A; Yoshida O
Int J Artif Organs; 1989 Aug; 12(8):544-8. PubMed ID: 2807601
[TBL] [Abstract][Full Text] [Related]
11. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
Zhang YY; Tang Z; Chen DM; Gong DH; Ji DX; Liu ZH
BMC Nephrol; 2014 Aug; 15():128. PubMed ID: 25086644
[TBL] [Abstract][Full Text] [Related]
12. Virus removal and eradication by modified double filtration plasmapheresis decreases factor XIII levels.
Hanafusa N; Satonaka H; Doi K; Noiri E; Fujita T
Ther Apher Dial; 2010 Jun; 14(3):287-91. PubMed ID: 20609180
[TBL] [Abstract][Full Text] [Related]
13. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Tagawa Y; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
[TBL] [Abstract][Full Text] [Related]
14. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
15. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
16. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation Effect and Safety Observation of Regional Citrate Anticoagulation for Double-Filtration Plasmapheresis in Critical Patients.
Peng X; Xie X; Yin J; Yu S; Zhang C; Zhao S
Blood Purif; 2020; 49(5):542-549. PubMed ID: 32191939
[TBL] [Abstract][Full Text] [Related]
18. Double filtration plasmapheresis can decrease factor XIII Activity.
Hanafusa N; Kondo Y; Suzuki M; Nakao A; Noiri E; Fujita T
Ther Apher Dial; 2007 Jun; 11(3):165-70. PubMed ID: 17497996
[TBL] [Abstract][Full Text] [Related]
19. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients.
Suzuki M; Yamane S; Matsugane T; Nobuto T; Azuma N; Nishide T; Shinomiya M; Saito K; Sasaki N; Nosé Y
Artif Organs; 1996 Apr; 20(4):296-302. PubMed ID: 8860710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
